Skip to main content

RT @RichardPAConway: Ramanan et al Baricitinib in JIA. Double blind withdrawal study of prior responders. Earlier flare

Social Author Name
Richard Conway
Tweet Content
Ramanan et al Baricitinib in JIA. Double blind withdrawal study of prior responders. Earlier flare with PBO vs bari (HR 0.24 [95%CI 0.13,0.45], p<0.001. Less flares with bari vs PBO (17.1% vs 50.6%) p<0.001 @RheumNow #EULAR2022 LB0002 https://t.co/22rp70njRu https://t.co/LtJE9dz0GT
Show on Archive Page
On
Display in Search Results
On
PDQ
Off